These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17077220)

  • 1. Alterations in CNS activity induced by botulinum toxin treatment in spasmodic dysphonia: an H215O PET study.
    Ali SO; Thomassen M; Schulz GM; Hosey LA; Varga M; Ludlow CL; Braun AR
    J Speech Lang Hear Res; 2006 Oct; 49(5):1127-46. PubMed ID: 17077220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin for the treatment of spasmodic dysphonia.
    Gibbs SR; Blitzer A
    Otolaryngol Clin North Am; 2000 Aug; 33(4):879-94. PubMed ID: 10918666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia.
    Ludlow CL; Naunton RF; Sedory SE; Schulz GM; Hallett M
    Neurology; 1988 Aug; 38(8):1220-5. PubMed ID: 3399071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of botulinum toxin in the treatment of adductor spasmodic dysphonia.
    Whurr R; Lorch M; Fontana H; Brookes G; Lees A; Marsden CD
    J Neurol Neurosurg Psychiatry; 1993 May; 56(5):526-30. PubMed ID: 8505645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of symptoms for spasmodic dysphonia and vocal tremor: a comparison of expert and nonexpert judges.
    Barkmeier JM; Case JL; Ludlow CL
    J Commun Disord; 2001; 34(1-2):21-37. PubMed ID: 11322567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceptual analyses of spasmodic dysphonia before and after treatment.
    Cannito MP; Woodson GE; Murry T; Bender B
    Arch Otolaryngol Head Neck Surg; 2004 Dec; 130(12):1393-9. PubMed ID: 15611398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin for treating spasmodic dysphonia (laryngeal dystonia): a systematic Cochrane review.
    Watts C; Nye C; Whurr R
    Clin Rehabil; 2006 Feb; 20(2):112-22. PubMed ID: 16541931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of using botulism toxin in the treatment of spasmodic dysphonia].
    Larrosa F; Idígora A; Aguilar F; Riera L; Martí MJ; Valls J
    Acta Otorrinolaringol Esp; 2002 Jan; 53(1):27-31. PubMed ID: 11998515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Speech intelligibility in severe adductor spasmodic dysphonia.
    Bender BK; Cannito MP; Murry T; Woodson GE
    J Speech Lang Hear Res; 2004 Feb; 47(1):21-32. PubMed ID: 15072525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acoustic variations in reading produced by speakers with spasmodic dysphonia pre-botox injection and within early stages of post-botox injection.
    Sapienza CM; Cannito MP; Murry T; Branski R; Woodson G
    J Speech Lang Hear Res; 2002 Oct; 45(5):830-43. PubMed ID: 12381042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of voicing and syntactic complexity on sign expression in adductor spasmodic dysphonia.
    Erickson ML
    Am J Speech Lang Pathol; 2003 Nov; 12(4):416-24. PubMed ID: 14658993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acoustic variations in adductor spasmodic dysphonia as a function of speech task.
    Sapienza CM; Walton S; Murry T
    J Speech Lang Hear Res; 1999 Feb; 42(1):127-40. PubMed ID: 10025549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to botulinum toxin injections for spasmodic dysphonia.
    Smith ME; Ford CN
    Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):533-5. PubMed ID: 10772310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.
    Troung DD; Rontal M; Rolnick M; Aronson AE; Mistura K
    Laryngoscope; 1991 Jun; 101(6 Pt 1):630-4. PubMed ID: 2041443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceptual structure of adductor spasmodic dysphonia and its acoustic correlates.
    Cannito MP; Doiuchi M; Murry T; Woodson GE
    J Voice; 2012 Nov; 26(6):818.e5-13. PubMed ID: 23177751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laryngeal image analysis following botulinum toxin injections in spasmodic dysphonia.
    Wong DL; Irish JC; Adams SG; Durkin LC; Hunt EJ
    J Otolaryngol; 1995 Feb; 24(1):64-8. PubMed ID: 7769649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of botulinum toxin treatment of spasmodic dysphonia: a review of 22 studies.
    Whurr R; Nye C; Lorch M
    Int J Lang Commun Disord; 1998; 33 Suppl():327-9. PubMed ID: 10343714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of botulinum toxin on pathophysiology in spasmodic dysphonia.
    Bielamowicz S; Ludlow CL
    Ann Otol Rhinol Laryngol; 2000 Feb; 109(2):194-203. PubMed ID: 10685573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spasmodic dysphonia: botulinum toxin injection after recurrent nerve surgery.
    Ludlow CL; Naunton RF; Fujita M; Sedory SE
    Otolaryngol Head Neck Surg; 1990 Feb; 102(2):122-31. PubMed ID: 2113236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term botulinum toxin dose consistency for treatment of adductor spasmodic dysphonia.
    Holden PK; Vokes DE; Taylor MB; Till JA; Crumley RL
    Ann Otol Rhinol Laryngol; 2007 Dec; 116(12):891-6. PubMed ID: 18217507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.